ERBB2 and neoplasm: Also patients having tumours expressing high HER2 together with high expressions of HER3 and HER4 had a better survival (Figure 2B) than did the patients expressing high HER2 but low HER3 and HER4 (P=0.0005) (Figure 2B, compare a with e).